Cytek Biosciences
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $52,293 | $45,602 | $41,457 | $57,476 |
Gross Profit | 27,551 | 23,867 | 20,157 | 33,652 |
EBITDA | -4,215 | -3,373 | -8,091 | -2,453 |
EBIT | -7,275 | -6,361 | -10,975 | -5,194 |
Net Income | -5,478 | -5,583 | -11,402 | 9,643 |
Net Change In Cash | 52,293 | 45,602 | 41,457 | 57,476 |
Free Cash Flow | -4,553 | -1,469 | -976 | 1,094 |
Cash | 93,281 | 75,470 | 95,298 | 98,716 |
Basic Shares | 127,547 | 126,934 | 128,339 | 129,205 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $200,453 | $193,015 | $164,036 | $127,950 |
Gross Profit | 111,106 | 109,426 | 100,974 | 79,144 |
EBITDA | -10,033 | -4,408 | 9,492 | 8,921 |
EBIT | -20,523 | -13,638 | 3,833 | 7,679 |
Net Income | -6,020 | -12,148 | 2,576 | 3,001 |
Net Change In Cash | 200,453 | 193,015 | 164,036 | 127,950 |
Cost of Revenue | -62,627 | 197,196 | ||
Free Cash Flow | 21,854 | 454 | -22,099 | 266 |
Cash | 98,716 | 167,299 | 296,601 | 364,618 |
Basic Shares | 130,611 | 135,283 | 138,562 | 133,749 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.0003 |
2025-06-30 | -$0.04 |
2025-03-31 | -$0.02 |
2024-12-31 | $0.12 |
